General Information of the Cell Line
Cell Line ID
CL000324
Cell Line Name
NCI-H3255
Synonyms
H3255
H-3255
H3255_DA
NCIH3255
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_6831
Tissue Information
Pleural effusion
Disease
Lung adenocarcinoma (NCIt: C3512)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00922, Epidermal growth factor receptor
Compound ID Compound Name Compound Formula
CP0852604
(R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
   Show/Hide
C25H24ClN7O2
 2
1
EC50 < 10 nM
   TI
   LI
   LO
   TS
2
GI50 = 75 nM
   TI
   LI
   LO
   TS
CP0033646
AZD-9291
   Show/Hide
C28H33N7O2
 4
1
GI50 = 33 nM
   TI
   LI
   LO
   TS
2
GI50 = 90 nM
   TI
   LI
   LO
   TS
3
IC50 = 4.1 nM
   TI
   LI
   LO
   TS
4
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0007430
IBRUTINIB
   Show/Hide
C25H24N6O2
 1
1
GI50 = 110 nM
   TI
   LI
   LO
   TS
CP0486473
3-[4-(3-bromoanilino)-6-methoxyquinazolin-7-yl]oxypropyl 3-(prop-2-enyldisulfanyl)propanoate
   Show/Hide
C24H26BrN3O4S2
 2
1
GI50 = 302.8 nM
   TI
   LI
   LO
   TS
2
GI50 = 787.3 nM
   TI
   LI
   LO
   TS
CP0871191
2-But-3-enyldisulfanyl-N-[4-(3-chloro-4-fluoro-phenylamino)-quinazolin-6-yl]-acetamide
   Show/Hide
C20H18ClFN4OS2
 1
1
GI50 = 348.6 nM
   TI
   LI
   LO
   TS
CP0911710
N-[4-(3-Bromo-phenylamino)-quinazolin-6-yl]-2-but-3-enyldisulfanyl-acetamide
   Show/Hide
C20H19BrN4OS2
 1
1
GI50 = 519.5 nM
   TI
   LI
   LO
   TS
CP0961271
3-Allyldisulfanyl-propionic acid 3-[4-(4-bromo-phenylamino)-6-methoxy-quinazolin-7-yloxy]-propyl ester
   Show/Hide
C24H26BrN3O4S2
 1
1
GI50 = 1348 nM
   TI
   LI
   LO
   TS
CP0871205
4-(4-{3-[4-(4-Bromo-phenylamino)-6-methoxy-quinazolin-7-yloxy]-propoxy}-phenyl)-[1,2]dithiole-3-thione
   Show/Hide
C27H22BrN3O3S3
 1
1
GI50 = 1408 nM
   TI
   LI
   LO
   TS
CP0871203
4-(4-{3-[6-Methoxy-4-(4-nitro-phenylamino)-quinazolin-7-yloxy]-propoxy}-phenyl)-[1,2]dithiole-3-thione
   Show/Hide
C27H22N4O5S3
 1
1
GI50 = 1874 nM
   TI
   LI
   LO
   TS
CP0871193
4-(4-{3-[4-(3-Bromo-phenylamino)-6-methoxy-quinazolin-7-yloxy]-propoxy}-phenyl)-[1,2]dithiole-3-thione
   Show/Hide
C27H22BrN3O3S3
 1
1
GI50 = 2404 nM
   TI
   LI
   LO
   TS
CP0871192
N-[4-(3-Chloro-4-fluoro-phenylamino)-quinazolin-6-yl]-2-[4-(3-oxo-3H-[1,2]dithiol-4-yl)-phenoxy]-acetamide
   Show/Hide
C25H16ClFN4O3S2
 1
1
GI50 = 4355 nM
   TI
   LI
   LO
   TS
CP0914491
4-(4-{3-[6-Methoxy-4-(3-trifluoromethyl-phenylamino)-quinazolin-7-yloxy]-propoxy}-phenyl)-[1,2]dithiole-3-thione
   Show/Hide
C28H22F3N3O3S3
 1
1
GI50 = 7472 nM
   TI
   LI
   LO
   TS
CP0911447
4-(4-{3-[4-(3,4-Dimethoxy-phenylamino)-6-methoxy-quinazolin-7-yloxy]-propoxy}-phenyl)-[1,2]dithiole-3-thione
   Show/Hide
C29H27N3O5S3
 1
1
GI50 = 8578 nM
   TI
   LI
   LO
   TS
CP0857303
(R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one
   Show/Hide
C25H26ClN7O2
 1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
CP0955273
4-(4-{3-[4-(3-Chloro-4-fluoro-phenylamino)-6-methoxy-quinazolin-7-yloxy]-propoxy}-phenyl)-[1,2]dithiole-3-thione
   Show/Hide
C27H21ClFN3O3S3
 1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
CP0876556
(R)-4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl 3-(Dimethylamino)pyrrolidine-1-carboxylate
   Show/Hide
C22H23ClFN5O3
 1
1
IC50 = 1.1 nM
   TI
   LI
   LO
   TS
CP0954214
N-(3-Chloro-2-fluorophenyl)-7-methoxy-6-morpholinoquinazolin-4-amine
   Show/Hide
C19H18ClFN4O2
 1
1
IC50 = 1.5 nM
   TI
   LI
   LO
   TS
CP0961577
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-morpholinoquinazolin-4-amine
   Show/Hide
C19H18ClFN4O2
 1
1
IC50 = 1.5 nM
   TI
   LI
   LO
   TS
CP0238701
N-[(3R,4R)-4-fluoro-1-[6-[(1-methylpyrazol-4-yl)amino]-9-propan-2-ylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide
   Show/Hide
C19H24FN9O
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0383723
N-[(3R,4R)-1-[6-[(1-ethyl-3-methoxypyrazol-4-yl)amino]-9-methylpurin-2-yl]-4-fluoropyrrolidin-3-yl]prop-2-enamide
   Show/Hide
C19H24FN9O2
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0961578
(1S,4S)-4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl 5-Methyl-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate
   Show/Hide
C22H21ClFN5O3
 1
1
IC50 = 2.3 nM
   TI
   LI
   LO
   TS
CP0145964
N-[1-[(3R)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]-7-methylbenzimidazol-2-yl]-2-(trifluoromethyl)pyridine-4-carboxamide
   Show/Hide
C27H31F3N6O2
 1
1
IC50 = 2.65 nM
   TI
   LI
   LO
   TS
CP0921289
(S)-4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl3-(Dimethylamino)pyrrolidine-1-carboxylate
   Show/Hide
C22H23ClFN5O3
 1
1
IC50 = 2.7 nM
   TI
   LI
   LO
   TS
CP0293062
N-[1-[(3R)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]-7-methylbenzimidazol-2-yl]-2-methylpyridine-4-carboxamide
   Show/Hide
C27H34N6O2
 1
1
IC50 = 3.05 nM
   TI
   LI
   LO
   TS
CP0921294
4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl Morpholine-4-carboxylate
   Show/Hide
C20H18ClFN4O4
 1
1
IC50 = 4.1 nM
   TI
   LI
   LO
   TS
CP0534799
N-[(3R,4R)-4-fluoro-1-[6-[[3-methoxy-1-(1-methylpyrrolidin-3-yl)pyrazol-4-yl]amino]-9-propan-2-ylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide
   Show/Hide
C24H33FN10O2
 1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CP0948665
4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl 4-Methylpiperazine-1-carboxylate
   Show/Hide
C21H21ClFN5O3
 1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CP0240838
N-[7-chloro-1-[(3R)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]benzimidazol-2-yl]-2-methylpyridine-4-carboxamide
   Show/Hide
C26H31ClN6O2
 1
1
IC50 = 6.11 nM
   TI
   LI
   LO
   TS
CP0036082
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
   Show/Hide
C22H24ClFN4O3
 1
1
IC50 = 6.5 nM
   TI
   LI
   LO
   TS
CP0041453
N-(3-chloro-2-fluorophenyl)-7-methoxy-6-(morpholin-4-ylmethyl)quinazolin-4-amine
   Show/Hide
C20H20ClFN4O2
 1
1
IC50 = 6.6 nM
   TI
   LI
   LO
   TS
CP0867043
4-[(3-Chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl (2S)-2,4-Dimethylpiperazine-1-carboxylate
   Show/Hide
C22H23ClFN5O3
 1
1
IC50 = 6.9 nM
   TI
   LI
   LO
   TS
CP0383724
N-[(3S)-1-[9-(2-hydroxyethyl)-6-[4-(4-methylpiperazin-1-yl)anilino]purin-2-yl]pyrrolidin-3-yl]prop-2-enamide
   Show/Hide
C25H33N9O2
 1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0065279
[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl] (2R)-2,4-dimethylpiperazine-1-carboxylate
   Show/Hide
C22H23ClFN5O3
 1
1
IC50 = 7.2 nM
   TI
   LI
   LO
   TS
CP0429196
1-[(3aS,6aR)-2-[6-[4-(4-methylpiperazin-1-yl)anilino]-9-propan-2-ylpurin-2-yl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]prop-2-en-1-one
   Show/Hide
C28H37N9O
 1
1
IC50 = 8 nM
   TI
   LI
   LO
   TS
CP0065286
AVL-301
   Show/Hide
C27H28F3N7O3
 1
1
IC50 = 13.8 nM
   TI
   LI
   LO
   TS
CP0316934
N-[7-methyl-1-[(3R)-1-prop-2-enoylazepan-3-yl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
   Show/Hide
C25H25F3N4O2
 1
1
IC50 = 14.84 nM
   TI
   LI
   LO
   TS
CP0543558
2-[4-(difluoromethyl)-6-[2-[4-[[4-(hydroxymethyl)piperidin-1-yl]methyl]phenyl]ethynyl]-7-methylindazol-2-yl]-2-spiro[6,7-dihydropyrrolo[1,2-c]imidazole-5,1'-cyclopropane]-1-yl-N-(1,3-thiazol-2-yl)acetamide
   Show/Hide
C37H37F2N7O2S
 1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
CP0873822
(S)-4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl 3,4-Dimethylpiperazine-1-carboxylate
   Show/Hide
C22H23ClFN5O3
 1
1
IC50 = 16.9 nM
   TI
   LI
   LO
   TS
CP0850399
(R)-4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl 3,4-dimethylpiperazine-1-carboxylate
   Show/Hide
C22H23ClFN5O3
 1
1
IC50 = 21.5 nM
   TI
   LI
   LO
   TS
CP0037987
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
   Show/Hide
C22H23N3O4
 1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0217163
N-[1-[(3R)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]-7-methylbenzimidazol-2-yl]-3-(trifluoromethyl)benzamide
   Show/Hide
C28H32F3N5O2
 1
1
IC50 = 45.9 nM
   TI
   LI
   LO
   TS
CP0419521
N-[5-methyl-1-(1-prop-2-enoylazepan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
   Show/Hide
C25H25F3N4O2
 1
1
IC50 = 74.9 nM
   TI
   LI
   LO
   TS
CP0961576
(4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)-(morpholino)methanone
   Show/Hide
C20H18ClFN4O3
 1
1
IC50 = 166 nM
   TI
   LI
   LO
   TS
CP0442242
N-[5-methyl-1-(1-prop-2-enoylpiperidin-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
   Show/Hide
C24H23F3N4O2
 1
1
IC50 = 421 nM
   TI
   LI
   LO
   TS
CP0534253
2-(5-fluoro-2-hydroxyphenyl)-2-[3-oxo-5-(4-piperazin-1-ylphenyl)-1H-isoindol-2-yl]-N-(1,3-thiazol-2-yl)acetamide
   Show/Hide
C29H26FN5O3S
 1
1
IC50 = 428 nM
   TI
   LI
   LO
   TS
CP0385108
N-[5-methyl-1-[3-[methyl(prop-2-enoyl)amino]phenyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
   Show/Hide
C26H21F3N4O2
 1
1
IC50 = 660 nM
   TI
   LI
   LO
   TS
CP0396216
N-[5-methyl-1-[3-(prop-2-enoylamino)phenyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
   Show/Hide
C25H19F3N4O2
 1
1
IC50 = 1041 nM
   TI
   LI
   LO
   TS
CP0428083
N-[5-methyl-1-[3-(prop-2-enoylamino)propyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
   Show/Hide
C22H21F3N4O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Pleural effusion)
Cell Line Name Organism Disease
U-937 Homo sapiens (Human) Adult acute monocytic leukemia
SU-DHL-1 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
SR Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
MC116 Homo sapiens (Human) B-cell non-Hodgkin lymphoma
K-562 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/A02 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/Adr Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/R7 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/DOX Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
MDA-MB-231 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-415 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-468 Homo sapiens (Human) Breast adenocarcinoma
SK-BR-3 Homo sapiens (Human) Breast adenocarcinoma
AU565 Homo sapiens (Human) Breast adenocarcinoma
CAL-51 Homo sapiens (Human) Breast carcinoma
CAL-120 Homo sapiens (Human) Breast carcinoma
DG-75 Homo sapiens (Human) Burkitt lymphoma
SUP-T1 Homo sapiens (Human) Childhood T lymphoblastic lymphoma
Pfeiffer Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
WSU-DLCL2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
Karpas-422 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
DoHH2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
KATO III Homo sapiens (Human) Down syndrome
GIST-T1 Homo sapiens (Human) Gastrointestinal stromal tumor
GIST-5R Homo sapiens (Human) Gastrointestinal stromal tumor
MZ-CRC-1 Homo sapiens (Human) Hereditary thyroid gland medullary carcinoma
L-428 Homo sapiens (Human) Hodgkin lymphoma
KM-H2 Homo sapiens (Human) Hodgkin lymphoma
T-47D Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T-47 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 MX100 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/VP Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D:A18 Homo sapiens (Human) Invasive breast carcinoma of no special type
MVLN Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF/MX Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/Topo Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7aro Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M6 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-10 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7piGST Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-Y1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/ADM Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7:WS8 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-FLV1000 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-neo/Her2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 cl.24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/DX1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-LC3 Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D-KBluc Homo sapiens (Human) Invasive breast carcinoma of no special type
Calu-6 Homo sapiens (Human) Lung adenocarcinoma
Calu-3 Homo sapiens (Human) Lung adenocarcinoma
HCC78 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3122 Homo sapiens (Human) Lung adenocarcinoma
NCI-H2122 Homo sapiens (Human) Lung adenocarcinoma
COR-L105 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1437 Homo sapiens (Human) Lung adenocarcinoma
HCC4006 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1792 Homo sapiens (Human) Lung adenocarcinoma
DFCI032 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1355 Homo sapiens (Human) Lung adenocarcinoma
NCI-H460 Homo sapiens (Human) Lung large cell carcinoma
U-1810 Homo sapiens (Human) Lung large cell carcinoma
COR-L23/R Homo sapiens (Human) Lung large cell carcinoma
H460/MX20 Homo sapiens (Human) Lung large cell carcinoma
H460R Homo sapiens (Human) Lung large cell carcinoma
H69AR Homo sapiens (Human) Lung small cell carcinoma
NCI-H69 Homo sapiens (Human) Lung small cell carcinoma
GLC-4/ADR Homo sapiens (Human) Lung small cell carcinoma
STC 1 Homo sapiens (Human) Lung small cell carcinoma
RERF-LC-A1 Homo sapiens (Human) Lung squamous cell carcinoma
Calu-1 Homo sapiens (Human) Lung squamous cell carcinoma
HCC95 Homo sapiens (Human) Lung squamous cell carcinoma
RERF-LC-AI Tet-off Homo sapiens (Human) Lung squamous cell carcinoma
NCI-H1650 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H1666 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H929 Homo sapiens (Human) Plasma cell myeloma
KMS-11 Homo sapiens (Human) Plasma cell myeloma
UTMC-2 Homo sapiens (Human) Plasma cell myeloma
KMS-12-PE Homo sapiens (Human) Plasma cell myeloma
NCI-H226 Homo sapiens (Human) Pleural epithelioid mesothelioma
Karpas-1106P Homo sapiens (Human) Primary mediastinal (thymic) large B-cell lymphoma